TY - JOUR
T1 - Bi-allelic ADPRHL2 Mutations Cause Neurodegeneration with Developmental Delay, Ataxia, and Axonal Neuropathy
AU - Danhauser, Katharina
AU - Alhaddad, Bader
AU - Makowski, Christine
AU - Piekutowska-Abramczuk, Dorota
AU - Syrbe, Steffen
AU - Gomez-Ospina, Natalia
AU - Manning, Melanie A.
AU - Kostera-Pruszczyk, Anna
AU - Krahn-Peper, Claudia
AU - Berutti, Riccardo
AU - Kovács-Nagy, Reka
AU - Gusic, Mirjana
AU - Graf, Elisabeth
AU - Laugwitz, Lucia
AU - Röblitz, Michaela
AU - Wroblewski, Andreas
AU - Hartmann, Hans
AU - Das, Anibh M.
AU - Bültmann, Eva
AU - Fang, Fang
AU - Xu, Manting
AU - Schatz, Ulrich A.
AU - Karall, Daniela
AU - Zellner, Herta
AU - Haberlandt, Edda
AU - Feichtinger, René G.
AU - Mayr, Johannes A.
AU - Meitinger, Thomas
AU - Prokisch, Holger
AU - Strom, Tim M.
AU - Płoski, Rafał
AU - Hoffmann, Georg F.
AU - Pronicki, Maciej
AU - Bonnen, Penelope E.
AU - Morlot, Susanne
AU - Haack, Tobias B.
N1 - Publisher Copyright:
© 2018 American Society of Human Genetics
PY - 2018/11/1
Y1 - 2018/11/1
N2 - ADP-ribosylation is a reversible posttranslational modification used to regulate protein function. ADP-ribosyltransferases transfer ADP-ribose from NAD+ to the target protein, and ADP-ribosylhydrolases, such as ADPRHL2, reverse the reaction. We used exome sequencing to identify five different bi-allelic pathogenic ADPRHL2 variants in 12 individuals from 8 families affected by a neurodegenerative disorder manifesting in childhood or adolescence with key clinical features including developmental delay or regression, seizures, ataxia, and axonal (sensori-)motor neuropathy. ADPRHL2 was virtually absent in available affected individuals’ fibroblasts, and cell viability was reduced upon hydrogen peroxide exposure, although it was rescued by expression of wild-type ADPRHL2 mRNA as well as treatment with a PARP1 inhibitor. Our findings suggest impaired protein ribosylation as another pathway that, if disturbed, causes neurodegenerative diseases.
AB - ADP-ribosylation is a reversible posttranslational modification used to regulate protein function. ADP-ribosyltransferases transfer ADP-ribose from NAD+ to the target protein, and ADP-ribosylhydrolases, such as ADPRHL2, reverse the reaction. We used exome sequencing to identify five different bi-allelic pathogenic ADPRHL2 variants in 12 individuals from 8 families affected by a neurodegenerative disorder manifesting in childhood or adolescence with key clinical features including developmental delay or regression, seizures, ataxia, and axonal (sensori-)motor neuropathy. ADPRHL2 was virtually absent in available affected individuals’ fibroblasts, and cell viability was reduced upon hydrogen peroxide exposure, although it was rescued by expression of wild-type ADPRHL2 mRNA as well as treatment with a PARP1 inhibitor. Our findings suggest impaired protein ribosylation as another pathway that, if disturbed, causes neurodegenerative diseases.
KW - ADPRHL2
KW - ARH3
KW - PARP
KW - ataxia
KW - cerebellar atrophy
KW - neurodegeneration
KW - neuropathy
KW - posttranslational modification
KW - ribosylation
KW - seizure
UR - http://www.scopus.com/inward/record.url?scp=85055102775&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2018.10.005
DO - 10.1016/j.ajhg.2018.10.005
M3 - Article
C2 - 30401461
AN - SCOPUS:85055102775
SN - 0002-9297
VL - 103
SP - 817
EP - 825
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 5
ER -